Evaluation of the anti-inflammatory properties of telmesteine on inflammation-associated skin diseases

Xu, X., Huang, D., Liu, W., Sheng, Z., Liang, K., Li, D., & Alharbi, N. S.

RSC Advances 7.55 (2017): 34699-34704.

Telmesteine, a useful agent for respiratory tract disorders, has been reported to be a critical active ingredient in topical compositions for dermatitis. The present study was designed to elucidate the in vitro and in vivo anti-inflammatory properties of telmesteine. LPS-induced NO production in RAW264.7 cells was significantly decreased after telmesteine treatment. TPA-induced skin inflammation as assessed by skin edema and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) was significantly decreased after telmesteine topical treatment. Further analysis results demonstrated that the anti-inflammation properties of telmesteine were associated with its ability to inhibit activation of nuclear factor kappa-κB (NF-κB) by blocking phosphoinositide 3-kinase/protein kinase B (PI3K/Akt)/IκB kinase (IKK) activities.

Evaluation-of-the-anti-inflammatory-properties-of-telmesteine-on-inflammation-associated-skin-diseases

Products Used in this Publication

Catalog NumberCASProduct NamePrice
122946-43-4122946-43-4TELMESTEINEInquiry

Related Products

Catalog NumberCASProduct NamePrice
B0001-1498097161-73-1Thiocholine iodideInquiry
B0001-16063111096-26-7ErythropoietinInquiry
B0001-186805203787-91-1Salcaprozate sodium, 99%Inquiry
B0001-3946391341-23-7Nicotinamide Riboside (Contain ~80% food grade dextrin as stabilizer)Inquiry